2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02781454 (ClinicalTrials.gov)	October 2016	10/5/2016	Mexiletine in Sporadic Amyotrophic Lateral Sclerosis	Effect of Mexiletine on Cortical Hyperexcitability in Sporadic Amyotrophic Lateral Sclerosis (SALS)	Sporadic Amyotrophic Lateral Sclerosis	Drug: Mexiletine;Drug: Placebo	University of Washington	Massachusetts General Hospital	Completed	18 Years	N/A	All	20	Phase 2	United States
2	NCT01849770 (ClinicalTrials.gov)	July 2013	6/5/2013	Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)	A Safety and Tolerability Study of Mexiletinein Patients With Sporadic Amyotrophic Lateral Sclerosis ...	Sporadic Amyotrophic Lateral Sclerosis	Drug: Mexiletine;Drug: Placebo	University of Washington	NULL	Completed	18 Years	N/A	All	75	Phase 2	United States
3	NCT01811355 (ClinicalTrials.gov)	May 2013	6/3/2013	Mexiletine for the Treatment of Muscle Cramps in ALS	Mexiletine for the Treatment of Muscle Cramps in ALS	Muscle Cramps in Amyotrophic Lateral Sclerosis	Drug: Mexiletine;Drug: Placebo	Bjorn Oskarsson, MD	University of California, Davis;ALS Association	Completed	21 Years	89 Years	All	23	Phase 4	United States
4	JPRN-UMIN000006423	2011/10/01	01/10/2011	The clinical trial to assess efficacy of mexiletine for amyotrophic lateral sclerosis		amyotrophic lateral sclerosis	administration of mexiletine and riluzole administration of riluzole only	Department of Neurology, Graduate School of Medicine, Chiba University, Japan.	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	60	Not selected	Japan

First Previous1Next Last